Vertex Pharmaceuticals Q1 2022 Earnings Preview
Vertex Pharmaceuticals (NASDAQ:VRTX) is scheduled to announce Q1 earnings results on Thursday, May 5th, after market close.
The consensus EPS Estimate is $3.54 (+18.8% Y/Y) and the consensus Revenue Estimate is $2.07B (+20.3% Y/Y).
Over the last 2 years, VRTX has beaten EPS estimates 88% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 2 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision  and 1 downward.